4//SEC Filing
LANDON JOHN H 4
Accession 0001079973-09-000090
CIK 0001167419other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 7:43 PM ET
Size
8.8 KB
Accession
0001079973-09-000090
Insider Transaction Report
Form 4
LANDON JOHN H
Director
Transactions
- Award
Stock Options
2009-01-27+50,000→ 50,000 total(indirect: By Trust)Exercise: $1.33From: 2009-01-27Exp: 2019-01-27→ Common Stock (50,000 underlying)
Holdings
- 17,035(indirect: By Trust)
Stock Options
Exercise: $5.87From: 2008-12-19Exp: 2018-12-18→ Common Stock (17,035 underlying) - 50,000(indirect: By Trust)
Stock Options
Exercise: $5.87From: 2008-12-19Exp: 2018-12-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]These options were granted to Mr. Landon pursuant to the Company's 2002 Stock Incentive Plan, and upon grant were assigned to a trust for which Mr. Landon serves as the trustee. The options vest annually on a pro-rata basis over a three year term. This transaction is exempt from Section 16(b) pursuant to Rule 16b-3(d).
Documents
Issuer
AspenBio Pharma, Inc.
CIK 0001167419
Entity typeother
Related Parties
1- filerCIK 0001200624
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 7:43 PM ET
- Size
- 8.8 KB